
    
      A Open-label, Single-center Study to Assess the Effect of the CYP3A4 inducer Rifampicin on
      the Pharmacokinetics of a 75 mg Single Oral Dose of Selumetinib (AZD6244; ARRY-142886)
      (Hyd-Sulfate) in Healthy Volunteers
    
  